Suppresses the insulin receptor and EGFR-transduced MAPK signaling pathway, but does not inhibit MAPK activation by a constitutively active mutant Ras.Probably impairs the formation of GTP-Ras.Inhibits Ras-independent, but not Ras-dependent, activation of RAF1.